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Abstract
Background: People admitted to psychiatric hospitals with a diagnosis of schizophrenia may display behavioural
problems. These may require management approaches such as use of coercive practices, which impact the well-
being of staff members, visiting families and friends, peers, as well as patients themselves. Studies have proposed
that not only patients’ conditions, but also treatment environment and ward culture may affect patients’ behaviour.
Seclusion and restraint could possibly be prevented with staff education about user-centred, more humane approaches.
Staff education could also increase collaboration between patients, family members and staff, which may further
positively affect treatment culture and lower the need for using coercive treatment methods.
Methods: This is a single-blind, two-arm cluster randomised controlled trial involving 28 psychiatric hospital
wards across Finland. Units will be randomised to receive either a staff educational programme delivered by
the team of researchers, or standard care. The primary outcome is the incidence of use of patient seclusion
rooms, assessed from the local/national health registers. Secondary outcomes include use of other coercive
methods (limb restraint, forced injection, and physical restraint), service use, treatment satisfaction, general
functioning among patients, and team climate and employee turn-over (nursing staff).
Discussion: The study, designed in close collaboration with staff members, patients and their relatives, will
provide evidence for a co-operative and user-centred educational intervention aiming to decrease the prevalence of
coercive methods and service use in the units, increase the functional status of patients and improve team climate in
the units. We have identified no similar trials.
Trial registration: ClinicalTrials.gov NCT02724748. Registered on 25th of April 2016.
Keywords: User-driven intervention, Patient-centred, Psychiatry, Aggression, Treatment culture, Cluster randomised,
Controlled trial, Effectiveness
* Correspondence: mava@utu.fi
1Department of Nursing Science, Faculty of Medicine, University of Turku ,
Turku, Finland
2School of Nursing, Hong Kong Polytechnic University, Hong Kong, China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Välimäki et al. BMC Psychiatry  (2017) 17:123 
DOI 10.1186/s12888-017-1266-6
Background
Mental disorders are among the most frequent and most
disabling non-communicable disorders. Every year over
38% of the total European Union (EU) population suffer
from mental disorders [1], and the lifetime prevalence
rate is 25% [2]. Mental health conditions are the one of
the most dominant contributors to the global economic
burden of non-communicable diseases, and schizophre-
nia constitutes the second greatest global burden in
terms of disability [3]. Schizophrenia is a severe mental
disorder characterised by profound disruptions in think-
ing, affecting language, perception, the sense of self and
impairing functioning through the loss of an acquired
capability to earn a livelihood [4]. However, schizophre-
nia is a treatable disorder: there is strong evidence that
antipsychotic medication and family psychoeducation
can improve outcomes for people with a diagnosis of
schizophrenia [5]. At the same time, challenging behav-
iour in people with serious mental disorders is an inter-
national concern. Although contradictory opinions exist
in the literature, the association between an increased
risk of violent behaviour and mental disorders has been
documented [6]. In regards to lifetime violence, a signifi-
cant association has been found with diagnosis of
schizophrenia and other psychotic conditions [7]. It is
also known that patients’ violent behaviour decreases
physical [8] and psychological health among staff mem-
bers in psychiatric inpatient care [9].
Discussion about the treatment of patients with aggres-
sive or self-harming behaviour is frequently accompanied
by an ethical conflict between patients’ autonomy on one
hand and the requirement to prevent harm on the other
[10]. The proportion of people who experience different
coercive measures is relatively small and numbers are de-
creasing [11–13]. However, frequencies of compulsory ad-
mission [14] and other types of coercion vary across the
EU [12]. Still seclusion, physical restraint and forced medi-
cation are used in many psychiatric hospitals [15, 16]. Ac-
cording to the recent health statistics in Finland, out of all
people treated in in-patient psychiatric care in 2014 (N =
25,552), 14% (3,329 patients) were exposed to coercive
methods [17]. Of those, 46% (1,520 patients) were isolated
in seclusion rooms, 21% (696 patients) were tied to a bed
with special belts in seclusion rooms (limb restrains), 24%
(787 patients) received forced injections, and 10% (326
persons) were physically restrained [17]. With regards to
the burden on families, relatives have experienced that in-
voluntariness in patient care has been associated with the
feeling of being excluded from treatment participation
[18]. From the perspective of patients, their experiences of
coercion are mainly negative [19–22]. As an outcome of
coercive measures, it was found in Finland that the
use of coercive measures was associated with increased
mortality of acute psychiatric hospital patients [23].
Less coercive measures and restrictive techniques are
being recommended for managing patient aggressive be-
haviour [24]. Some actions have already been taken to
decrease seclusion and restraint [25–29]. Putkonen et al.
[27] found that, in state hospital wards for men with
schizophrenia and violent behaviour, seclusion and re-
straint could be prevented with staff education and with-
out an increase of violence. Some evidence has also
shown that less restrictive interventions, such as cogni-
tive skills programmes [30] or short-term risk assess-
ment [31], have some effects in decreasing the number
of aggressive incidents on psychiatric wards.
Still, use of less restrictive interventions to manage ag-
gressive patients is controversial [32]. Institutional or-
ganisation and clinical responsibility has traditionally
aimed to provide a structured and safe environment for
patients, to facilitate and monitor their treatment pro-
cesses [33]. However, a clinical trial in Brazil by Huf et
al. [34] found some limited evidence that using less re-
strictive measures did not harm patients, such as in-
crease overall time of being restricted. Bergk and
colleagues [35] in their clinical trial in Germany showed
that patients did not show a clear difference between
coercion experiences after seclusion or mechanical
restraint use although contrary experiences have also
displayed with low quality study methodology [36].
Despite the controversy of this topic, there is a need to
establish, in collaboration with various parties, humane
evidence-based interventions for prevention of aggres-
sive behaviour among psychiatric patients [37]. Critical
assessment of the content of patient treatment, as well
as the consideration of patients’ and family members’
voiced opinions and concerns, are too often neglected
by services, even though they are included in modern
treatment agendas [38]. Procedures used for dealing with
patients’ behavioural problems are still largely based
on the needs of staff and are untested in comparative
studies [24]. On the other hand, if new interventions
are being used, descriptions of the content of the new
interventions are often incomplete which hinders
their implementation in practice [39–41]. There is
also a lack of knowledge, which elements of interven-
tions or programmes are effective or which mecha-
nisms or processes have a real impact [37]. In
addition, staff members may have their own untested
traditions how to manage patients’ challenging behav-
iour on the wards because they are not always
sufficiently aware which interventions are more cost-
effective [42, 43] or are more effective, particularly in
managing aggressive patient behaviour [40, 44] than
others. Finally, the understanding of aggressive patient
events is still unclear and there is a lack of studies
investigating causal associations between risk factors
and patient violence [45].
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Positive experiences of making a difference in a wider
context can also be found. The recent large-scale trials
covering wide geographical areas in the United Kingdom
[46–49], South Africa [50] and Switzerland [51] have en-
couraged us to design and conduct a nation-wide cluster
randomised clinical trial to test the effects of user-
centred and collaborative intervention to prevent and
decrease coercive events in psychiatric hospitals.
Contrary experiences of the impact of large-scale inter-
vention trials also exist. Thornicroft et al. [52] found in
their study (64 generic and specialist community mental
health teams) that the Joint Crisis Plan (JCP) was not
significantly more effective than usual treatment. One
reason was that the JCP was not fully implemented in all
study sites, and it was combined with routine clinical
review meetings, which did not actively incorporate pa-
tients’ preferences. Other studies have also found prob-
lems in new working methods, which may hinder their
use in clinical practice. These problems include, for ex-
ample, that interventions have been difficult to adhere
to, use and to adopt into routine care [53]. Other hin-
drances related to the assessment of the new methods
have been slow patient recruitment [54] and sudden
changes in local mental health policies [35]. In Norway,
Aakhus et al. [55] examined in a cluster randomised trial
with 80 municipalities, whether adherence to treatment
guideline recommendations for elderly patients with de-
pression could be approved by targeting healthcare pro-
fessionals, patients and administrators. They found that
the effectiveness of tailored intervention in implement-
ing recommendations for elderly patients with depres-
sion in primary care was uncertain. Further, a one-year
team-level intervention (14 teams in the REFOCUS
group, 13 in the control group) did fail to coach staff be-
haviour toward a positive partnership between staff and
patients with psychosis [56].
Although treatment systems in psychiatric hospitals
have already developed toward having more positive ap-
proaches [57], the importance of developing interven-
tions and making ward atmospheres more active and
caring should not be forgotten [37, 58–60]. Recently
Boumans et al. [37] described a reduction in the use of
seclusion in a psychiatric setting. Patients and families
worked together, in close collaboration, which included
cyclic evaluation and readjustment of the treatment and
a nurse care plan. Implicit, positive changes were found
in the team process, such as increased interdisciplinary
collaboration, team cohesion, and professionalization.
Our previous small-scale project (funded by the Finnish
Work Environment Fund, 111298) also identified the
need and promises in improving ward atmospheres in
psychiatric hospitals by educating staff members toward
close collaboration between patients, relatives and staff
members [20, 61–64]. In the randomised controlled trial
(RCT), we will also use user-driven approach [65] that
includes, close collaboration with patients, staff, and
family members in implementing the intervention in
clinical practice and listening and accounting for their
preferences and needs in daily practice [66]. The focus
of the approach will therefore be bottom-up rather than
top-down [67]. However, this requires stronger effort in
our intervention in organising meetings, discussions and
workshops with end-users to ensure everyone is aware
of end-user needs and preferences.
In this study, we will implement an educational
intervention for nursing staff to improve treatment
culture on psychiatric wards and support team cli-
mate in staff members in psychiatric hospitals with a
nation-wide cluster trial to test the effects of the edu-
cational intervention to decrease coercive incidents in
psychiatric hospitals.
Methods
Aim of the study
To compare the effects of an educational intervention to
usual practice (standard care, no specified staff educa-
tion) on improving treatment culture and supporting
team climate in staff members, which further could re-
duce the need for the use of coercive methods in psychi-
atric care. Although the intervention is designed to
impact the daily practice and treatment culture of each
hospital organisations, our attempt is also to improve
outcomes at the level of the individual patient and nurs-
ing staff. Therefore, the outcomes of the study will be
assessed from the organisational, patients’, and staff
members’ points of view.
The primary objective is to investigate whether the
educational intervention for staff will decrease the inci-
dence of patient restrictions - specifically use of seclu-
sion rooms on psychiatric wards of hospitals. The
secondary objectives are to investigate whether the edu-
cational intervention changes the incidence of limb re-
straint, forced injection, physical restraint and service
use in psychiatric hospitals. The study will also investi-
gate whether the educational intervention for staff mem-
bers changes patients’ functional capacity, level of
treatment satisfaction and quality of life. From the point
of view of the nursing staff, the study will investigate
whether the educational intervention effects team
climate and staff turn-over.
Trial design
Our study is a single-blind, two-arm, stratified cluster
randomised trial.
Setting and sample
This is a nation-wide study to be conducted across
Finland in hospitals with psychiatric beds. Finnish
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mental health services are arranged by municipalities (N =
317 [68]), each individual municipality forms joint munici-
pal authorities with other municipalities, or hospital dis-
tricts, and are supplemented by private and third sector
services (e.g. associations and foundations). People in need
of inpatient psychiatric care are treated in general health
services (e.g. health centres) or specialised medical care ser-
vices organised by hospital districts [69]. This study will be
conducted in hospitals with psychiatric beds in the non-
private sector. Hospitals as cluster will be recruited and
randomised.
Inclusion criteria of required participating hospital or-
ganisations are: Finnish-speaking, to have at least 1 psy-
chiatric ward, open 24 h a day, seven days a week, and,
when necessary, are able to use coercive measures de-
fined in the Finnish Mental Health Act (1116/1990, [70])
(seclusion room, limb restraint, forced medication, phys-
ical restraint). Wards will be excluded if they are specia-
lised in forensic, psychogeriatric, or child and adolescent
mental health care alone or if a similar type of project is
underway or is planned to start there. In total there are
28 eligible hospitals. Once a hospital is allocated to any
comparison arm, all health care professionals working in
wards of the hospital and patients admitted to those
wards are eligible to participate to the study. Based on
the Finnish health statistics of the National Institute for
Health and Welfare [17], patients with a primary diagno-
sis of schizophrenia represents the second most com-
mon diagnostic group in psychiatric hospitals, after
people with depression or recurrent depressive disorder
[17]. People with schizophrenia are treated in psychiatric
hospitals if they are in an acute phase and need for spe-
cialized care: 60% of all hospitalised patients in 2014
were hospitalised through an emergency admission [17].
Study procedure
Recruitment and randomisation
Written information letter describing the study are to be
sent to the administrators of each hospital organisation.
They are given up to four week-time to show their pre-
liminary interest and willingness to participate. This
allows an adequate time for them to think through their
decision and ask any questions related to the study.
Hospital organisations, within which there will be eli-
gible wards, agreeing to participate will be randomly
allocated to either receive staff education intervention
(intervention group) or not receive staff education
(passive control group). This allocation is organised by
the research group as soon as baseline information of
the wards is collected. The unit of randomisation is the
hospital organisation within which there will be psychi-
atric wards. The cluster design will be used to avoid con-
tamination in intervention effects between individual
staff members. We will use centralised randomisation at
the University of Turku (Department of Mathematics
and Statistics) stratified by number of patient beds and
nursing staff to assure as similar number of participants
as possible in the intervention group as in the passive
control group. Randomisation will be fully concealed
and computer-generated by an independent statistician,
who is not involved in the study. Investigators enrolling
wards will not be able to foresee the assignment.
Data analysts will be kept blinded to allocation. Due to
the type of intervention, allocation will be unmasked
after randomisation to patients and their relatives, con-
tact persons on each ward, health care staff delivering
patient care on the wards, and the researchers participat-
ing in the intervention design and implementation; this
will reflect real-world care. The Data Management
Committee (DMC) will undertake ongoing safety sur-
veillance. Investigators running the preliminary analysis
for the DMC will be masked to data until investigators
release the database. In addition, the statisticians and the
National Register holder [71] responsible for Finnish
routine data used in this study will be masked to ward
allocation and patient data in each arm.
Local medical registers in each study hospital will form
the data base of the study. For patient survey, staff in
sampled hospitals will recruit every Finnish speaking pa-
tients and over 18 years admitted and treated on the
wards during the patient data collection period before
their discharge to achieve a sufficient sample of patients
in anonymous survey. Inclusion criteria are patients aged
over 18 years, of either sex, on discharge from a psychi-
atric hospital, are able to use the Finnish language, and
are able to participate in the study based on their free
will. Returned completed questionnaire will be inter-
preted as a voluntary participation in this study. We will
include no formal test of capacity but will rely on the
judgment of experienced health care professionals in
their routine assessment, when nearing the point of
discharge. Further formalized assessment is not part
of routine care.
Patients who are under 18 years, incapable to use the
Finnish language or judged to be not capable to partici-
pate in the study based on their mental status will be
excluded.
The flow of the study is described in Fig. 1. Flow
diagram.
Study interventions
Intervention units
The overall aim of the intervention is to encourage col-
laborative practices between staff, patients and family
members that will lead to the adoption of a less coercive
treatment approaches in the ward. The intervention is
designed to impact treatment culture and thereby treat-
ment practices on the study wards. We hope to improve
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outcomes at the level of the organisation, patients, and
staff members. To achieve the study goals we will sup-
port skill developments, intellectual resources, motiv-
ation and encouragement of staff members to make
practical changes on the ward practices.
A pilot study has been undertaken with staff members,
patients and relatives in one hospital ward not included
in the study. This ensured acceptability of the interven-
tion, readability and usefulness of all steps and of the
educational content and materials, acceptability for the
target population, understanding of the messages, coher-
ence of the programme and feasibility of the time schedule.
Based on the pilot, the intervention includes components
based on Glasziou’s and Haynes’ [72] pathway to improve
health outcomes:
1. Staff education: identification of problems in current
treatment practices, and analysis of the local house
rules and quality of the service facilities (involves
interviews with patients, families and staff ) [73]. The
quality gaps and areas to be developed will be described
and future steps for the development will be decided.
Knowledge about evidence-based studies how to fill
possible quality gaps will be shared with staff members,
and strengths, weaknesses, opportunities, and threats
(SWOT) related to the future changes will be captured.
(Acceptance)
2. Local meetings: involvement of staff members,
patients, relatives, and the trial team to specify
detailed areas to be developed and the specific steps
to be taken. Possible barriers and facilitating factors
for change will be identified. (Applicability)
3. Shared information packages: intervention materials
to support staff ’s competence will be made available.
(Available)
4. Support available from the project team: monthly
monitoring and support calls or emails as to prompt
and encourage change in staff members. (Able)
5. Implementation: hands-on-support provided by the
trial team. The contact persons will work with the
staff to help them gain confidence in the new ideas
of the intervention. The understanding of the
intervention will be reviewed (Interim Evaluation).
(Acted on)
6. Identification of the possible change: the use of
coercive methods and house rules will be
analysed, and possible differences in situation in
baseline and after intervention, such as practices,
and treatment methods and associated with
patient care will be analysed and shared with staff
members. (Agreed on)
7. Awareness of engagement and motivation: treatment
practices and outcomes will be monitored and
evaluated by the trial team. The team, working with
Fig. 1 Protocol flow diagram
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the contact persons on the wards, will, in collaboration
with staff members, assess how specific intervention
fidelity criteria have been fulfilled [74]. (Adhered to)
A summary of the intervention is described in Table 1.
Comparison unit
Wards allocated to the control arm (standard care, pas-
sive control group) will continue with their usual care,
and staff will not receive additional education offered by
the trial team. There are no restrictions on how nursing
staff work in these wards, although participation in cor-
responding projects is not supported. Any workshop
seminars, local meetings, outreach visits or structured
monitoring or support will not be organised in the com-
parison wards. As in the intervention hospital organisa-
tions, any analysis of the current treatment problems or
possible quality gaps to be shared with the staff mem-
bers will not be collected or shared by interviews or ob-
servations. Any information packages aiming to support
their positive treatment culture will not be shared with
the staff members working in these hospital organisa-
tions. The trial team will contact the control wards only
to collect baseline data of the wards and the outcome
data. After the 18 months intervention and follow-up
period, comparison wards will be given a possibility to
participate in workshops and seminar related to the
intervention.
Measures
Background information
Patients: The demographic information of the patients
(age, gender, marital status, educational level, housing,
employment status, number of psychiatric hospital
treatment periods, the time of first contact with psy-
chiatric services) will be collected as part of a patient
follow-up survey.
Demographics of unit of randomisation: The following
information about the units will be described: a number
of hospital beds, a number of patients, bed/patient ratio,
a number of treatment periods, an average length of
stay, gender ratio, patient average age, three most com-
mon diagnose (ICD-10) [75], and a number of staff/pro-
fessional group. In addition, a short description of the
ward type and treatment methods will be asked.
Primary outcome
Organisational outcomes
The primary outcome of the study is the incidence of se-
clusion room use by patients in each unit. This will be
assessed based on local (and national, if possible) health
registers (Finnish Mental Health Act 1116/1990, [70]).
The outcome will be measured at three time points:
baseline (in 2015) based on local register (at the end of
2016), year 2016 (at the beginning of 2017), and year
2017 (at the beginning of year 2018). Information
collected from each organisation is comparable across
Table 1 Description of the intervention according to the TiDieR (modified based on Hoffman [99])
Categories Description of the intervention
Name Educational intervention to support positive treatment culture and team climate in staff members in psychiatric hospitals
Rationale/Theory Patients’ conditions, treatment environment and ward culture may affect patients’ behaviour. Use of coercive methods
could be prevented with staff education about user-centred if more humane approaches as well as collaboration between
patients, family members and staff members could be increased. Staff education may further positively affect treatment
culture and lower the need for using coercive methods in psychiatric hospital care. [46–51]
Materials Information about evidence-based research, written information package of intervention materials, and monitoring tools.
Procedures Identification and analysis of current treatment practices, local house rules and quality of the service facilities. Identification
of quality gaps, SWOT, barriers and facilitators for change. Dissemination of research evidence. One-day workshop seminars,
local meetings and outreach visits. Ongoing monitoring and support by calls/emails.
Providers Trial team: with a background of psychiatric care as nurses/researchers, an academic qualification (master and/or doctoral level)
with an experience in continuing education of staff members (professor, senior researcher, project researcher, doctoral student,
master students).
Staff members: different health care professionals.
How Face-to-face seminars with lectures, workshops, group meetings, outreach visits, telephone and email contacts with staff
members. If needed, video meetings will be organized with staff members.
Where At the psychiatric wards and at the University facilities (workshops, seminars).
When and how much Intervention will take 18 months:
- Identification, analysis and sharing current treatment practices, use of coercive methods, local house rules, and quality
of the service facilities (months 1–4)
- Identification of quality gaps, SWOT analysis in workshop and local meeting, barriers and facilitators for change in each
ward, and dissemination of research evidence in workshop; one-day workshop seminars, local meetings and outreach
visits (months 5-8),
- Ongoing support by calls/emails provided, workshop, local meetings (months 9–18).
Tailoring and
modifications
The education process with specific protocol is similar at each ward. The activities taken on each ward based on the need
analysis and the quality gaps may be tailored to fulfil the needs of each ward.
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hospital organisations. The national register holder, Care
Register for Health Care [71] gives instructions on how
the information regarding treatment notifications shall
be collected, recorded and sent annually to the National
Institute of Health and Welfare. To ensure that the in-
formation about incidence of seclusions can be obtained
in full detail, data will be collected either manually based
on nurses’ notes and/or medical registers at the local
organisations.
Secondary outcomes
Organisational outcomes
Other types of coercive measures: incidence of other
types of coercive measures used on patients (limb re-
straint, forced injection, physical restraint) according to
the Finnish Mental Health Act (1116/1990, [70]) (yes/
no), including the frequency and/or length (in minutes,
if possible) of these measures. The outcome will be mea-
sured at three time points: baseline based on local regis-
ter from year 2015 (at the end of 2016), year 2016 (at
the beginning of 2017), and year 2017 (at the beginning
of year 2018). Information to be collected in each organ-
isation will be comparable based on the instructions of
data recording by the National Institute of Health and
Welfare. The data will be collected either manually
based on nurses’ notes and/or medical registers at the
local organisations.
Service use (collected from local and/or national regis-
ters): type of admission, length of stay (days), death [yes]).
The data will be collected either manually based on
nurses’ notes and/or medical registers at the local organi-
sations. Information to be collected in each organisation is
comparable based on the instructions of data recording by
the National Institute of Health and Welfare [71]. The
outcome will be measured at three time points: baseline
based on local register from year 2015 (at the end of
2016), year 2016 (at the beginning of 2017), and year 2017
(at the beginning of year 2018).
Staff outcomes
Team climate among nursing teams (Team Climate
Inventory, TCI, 38 items [76, 77]) will be surveyed at
baseline and 18-20 months after beginning of the inter-
vention. The inventory consists of four subscales; partici-
pative safety, support for innovation, vision and task
orientation. Items in subscales of participative safety and
support for innovation are measured with 5-point
Likert-type scale, while subscales of vision and task
orientation are measured with 7-point Likert-type scale.
Higher scores indicate better team climate [77]. In the
Finnish population, subscales of the inventory have dem-
onstrated high internal consistency (Participative safety
α = 0.88; Support for innovation α = 0.87; Vision α =
0.95, Task orientation α = 0.91 [78]) and moderate
correlations (r = 0.36-0.48) with other methods assessing
team innovativeness [79].
Turnover will be measured at baseline (based on local
register data from 2015), year 2016 (at the beginning of
2017), and year 2017 (at the beginning of year 2018).
Patient outcomes
The functional capacity of patients (Global Assessment
Scale, GAS [80]), rated by staff members at the time of
the discharge process, will be assessed. The value of the
measure can vary between 0 and 100. Higher scores in-
dicate better functional capacity of patients [80]. The
scale has demonstrated high inter-rater reliability (r =
0.72) and significant correlation (r = - 0.64) with other
scales used to assess the symptom complexity of pa-
tients [81]. The measuring of this outcome will begin
9 months after beginning of the intervention (at the
beginning of 2017).
Patient treatment satisfaction (Client Satisfaction
Questionnaire, CSQ-8, 8 items [82]) will be assessed
with a structured paper survey for every patient at the
time of their discharge process. Patients respond to the
questions using a 4-point Likert scale. Responses are
scored from 1 to 4, and thus the possible total scores
range from 8 to 32. Higher scores indicate greater satis-
faction with treatment [82]. The survey has demon-
strated a high level of internal consistency (Cronbachs’ α
0.92) and significant correlation (r = 0.67) to other
methods used to measure treatment satisfaction [83].
The measuring of this outcome will begin 9 months
after beginning of the intervention (at the beginning
of 2017).
Quality of Life (Quality of Life Enjoyment and Satisfac-
tion Questionnaire-Short Form, Q-LES-Q-SF, 16 items
[84]) will be assessed with a structured paper survey for
every patient at the time of their discharge process. Each
of the 16 items is rated on a 5-point scale that indicates
the degree of enjoyment or satisfaction experienced dur-
ing the past week. Higher scores on indicate greater con-
tentment or satisfaction [84]. In the Finnish psychiatric
patient population, this instrument has demonstrated
high internal consistency (Cronbachs’ α = 0.89) and
moderate correlation with other methods used to assess
quality of life (r = 0.445) [85]. The measuring of this out-
come will begin 9 months after beginning of the inter-
vention (at the beginning of 2017).
Feasibility of the intervention
Feasibility of the intervention will be analysed from or-
ganisation, staff members, and patients’ point of views.
Acceptability (willingness of patients to participate,
satisfaction with the intervention, willingness to
continue the intervention), implementation (degree of
execution), integration (drop out), and practicality
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(easy to use, yes/no) [86], in daily practice will be
assessed at the end of the study.
Fidelity and quality components of the intervention
The fidelity of the intervention and staff adherence to
the intervention will be supported and assessed (Table 2).
Each item completed achieves a score of 0-1.00, giving a
total percentage of 0%-100%. Lastly, the final seminar
will be organised by the team in conjunction with the
intervention units.
The strengths, weaknesses, opportunities, and threats
related to the new practices will also be discussed and
categorised based on a SWOT analysis. Possible barriers
and facilitating factors for change in each unit will be
identified during workshops and outreach visits. Further,
to gain a deeper understanding of staff members’ will-
ingness to engage themselves in the new approach in
practice, interviews will be conducted at the last phase
of the study for staff members, patients and relatives.
Their perceptions of human treatment environment with
the following topics will also be assessed: a) Uniqueness
of the individual; b) Real choices; c) Attitudes and rights;
d) Dignity and respect; e) Partnership and communica-
tion; and f ) Evaluating recovery-oriented mental health
practice [73]. Convenience sample method will be used
to recruit participants into the interviews (N = 50% staff
members and patients from a unit and 25% patients’
relatives will be interviewed [73]). In addition, their
opinions about the possible changes at the units will
be discussed.
Data management
All original paper and electronic data will be managed
and held in accordance with the University of Turku
and the national standards of the Finnish Personal Data
Act (523/1999, [87]), partner organisations’ special re-
quirements, and the health care organisations’ policies
and national acts. The Council for International Organi-
zations of Medical Sciences (CIOMS [88]) and the
Declaration of Helsinki [89] will be followed, to ensure
Table 2 Implementation stages and fidelity criteria of the process based on Glasziou and Haynes et al. [72])a
Implementation stage Fidelity criteria
Acceptance
A one-day workshop (X2) for ward managers and contact persons will
be organised by the trial team; the results of the information collected
at baseline will be shared; preliminary action plans for units will be
designed; queries from the staff will be answered.
A local ward meeting will be organised by the senior ward manager
and a contact person on each intervention ward. House rules for patients
will be collected and analysed from each ward.
At least one ward manager/contact person in each intervention unit
will attend the one-day workshops (1st and 2nd workshop) (80%).
The first local meetings will be organised and documented on each
ward (100%).
House rules will be analysed (100%).
Applicable
A series of local meetings with staff members, patients, and relatives will
be organised by the trial team; areas to be developed and specific steps
to be taken will be identified; barriers and facilitating factors for change
will be described; strengths, weaknesses, opportunities, and threats related
to the educational intervention will be identified through a SWOT analysis.
The first outreach visit on each ward will be organised (100%).
At least 50% of staff on each ward will attend the first outreach visit.
Available
An information package of an intervention to support staff’s competence
will be available.
An Action Plan for each ward will be developed (100%); the content
of the information package will be shared with the staff (100%).
Able
Monthly monitoring/support calls/emails by the trial team will prompt
and encourage changes on the wards.
Ward managers/contact persons or senior ward managers will report
the progress of the changes (including harms) by email/telephone
(12 calls or email/12 months; 100%).
Acted on
The trial team will visit each ward to give hands-on support to staff
members, ward managers and contact persons so that they will gain
confidence in implementing the new ideas on the wards. The Action
Plan will be revised if needed.
A one-day workshop for an Interim Evaluation Seminar will be organised.
The second outreach visit on each ward will be organised. At least 50%
of the staff on the ward will attend the visits.
The third workshop will be organised to review the implementation
process; at least one person from each unit will attend (Interim Evaluation)
(95%).
Agreed on
Outcome assessment and house rules will be analysed by staff members
and the trial team; possible differences in previous and current actions will
be identified.
Patient coercive methods and house rules will be analysed (100%).
Adhered to
Daily practices will be monitored by the trial team.
The final workshop will be organised.
Daily practices will be monitored and outcomes of the intervention will
be evaluated in a meeting on each ward.
The third outreach visit on each ward will be organised. At least 50% of
the staff on the ward will attend the visits.
At least one senior ward manager/contact person in each intervention
unit will attend (95%) the fourth workshop.
aKillaspy et al. [74]
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confidentiality of data. The material for the study will be
mainly obtained from local registers, case notes and na-
tional health registers, and through patient and staff sur-
veys. Data will be in paper and electronic format and
saved electronically for statistical analysis. The qualita-
tive data will be digitally recorded and transcribed to be
analysed in written format. Members of the DMC are
representatives from the ethical board, mental health as-
sociations, hospitals and hospital districts, national
health and welfare institute, and statistics. Their role is
to support, advice and evaluate the trial as well as inter-
vention and outcomes. They also provide guidance
related to financing, modifications, timing, risk manage-
ment and quality assurance. The DMC have meetings
twice a year.
Power and sample size
We have systematically searched for, but found no dir-
ectly relevant past work [31, 90]. We assume that if the
data will be obtained from local hospital registers by
sampling 7 clusters (hospitals) with 265 subjects each in
intervention group and 7 clusters with 265 subjects each
in control group, we will have 80% power to detect a dif-
ference between the group proportions of−0.0400. The
control group proportion is 0.1100. The intervention
group proportion is assumed to be 0.1100 under the null
hypothesis and 0.0700 under the alternative hypothesis.
The test statistic used is the two-sided Z test (unpooled)
with an overall significance level at 0.05. We may as-
sume based on the hospital registers that sample size for
the total population admitted in the study wards in one
year will be 3710. However, if we consider a loss of 20%
patients in the local care registers, [91] the total number
of patients on the randomised wards should be about
4454 patients. (PASS 11 software [92]). Further, if we as-
sume 50% response rate for patient survey [93] out of
possible 3710 participants, we will assume that we will
obtain 928 filled questionnaires during 6 month survey
data collection period. The sample size calculation was
adjusted for intra-cluster correlation at 0.005.
Data analysis
Statistical analysis
The Data Management Committee including a statisti-
cian outside of the research team will verify the statis-
tical analysis and the Quality Assurance Process.
The baseline characteristics of the units, and respon-
dents (patients, staff members) will be summarised using
descriptive analysis (mean [standard deviation], median
[interquartile ranges] or proportions) and compared be-
tween each intervention group, respectively.
The analysis will be carried out on an intent-to-treat
(ITT) basis. Assumptions of normality of the residuals
will be investigated. For the primary outcome, incidence
of coercion methods used at the baseline (year 2015),
year 2016 (at the beginning of 2017), and year 2017 (at
the beginning of year 2018) will be calculated. Possible
differences in patient characteristics between the inter-
vention and the control group at baseline will be tested
by Chi-Square or t-tests based on type of variables. This
analysis will help to decide whether baseline characteris-
tics of patients should be adjusted for in the model for
the primary outcome comparison after intervention. The
hierarchical (participant nested within ward) Poisson
model will be used to estimate and test the relative risk
of being coerced in the intervention and the control
group, which takes into account the length of staying of
patient’s in hospitals. With the same principle, for sec-
ondary outcomes, a hierarchical linear model will be
used for normally distributed variables such as patient
satisfaction and team climate, a hierarchical logistic
model for dichotomous outcomes such as any admission
or any adverse event, and the Poisson model for hospi-
talisation stay lengths or time spent in a seclusion room.
A sensitivity analysis will be conducted by comparing
the primary data at the follow-up and the fidelity infor-
mation [47]. If poor fidelity was found for the primary
data, we may consider evaluating change rate of coercive
methods use between the two groups using all three
measures over time by applying repeatedly measured
models with random effects of hospital clusters. The re-
sults from the secondary analyses will be treated as ex-
ploratory. Estimates and confidence intervals will be
reported only. The CONSORT guidelines for rando-
mised trials [94] will be followed throughout our data
analysis and the reporting of our study results. This
study protocol follows the recommendations of the
SPIRIT Statement [95].
Qualitative analysis
Qualitative data (SWOT analysis, possible barriers and
facilitating factors for change, engagement in the new
approach) will be analysed by thematic categorisation. A
combination of deductive and inductive approaches will
be used to gain an understanding of data. First, the taped
interview data will be transcribed by researchers, which
will be overseen by MV and MA to increase consistency,
supervision and support the appraising process of the re-
search group. The researchers will introduce themselves
in the transcripts. Its content will be coded and further
categorised by the specific themes by methods of Braun
and Clarke’s [96] phases of analysis process. Further, the
validity and reliability of the coding will be checked by
MA and TL by recoding and defining categories from a
random sample of pages of the transcripts. For the quali-
tative data, the COREQ checklist by Tong et al. [97] will
be used for reporting.
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Dissemination
The Department of Nursing Science at the University of
Turku in Finland is nationally and internationally known
for its research related to aggression in mental health
care. It is also one of the leading research centres focus-
ing on preferences of patients and nursing staff within
the field in Finland. The Academy of Finland, as a main
funder, together with Turku University Hospital, the
University of Turku, in close collaboration with Hong
Kong Polytechnic University of China (SAR), is provid-
ing the research infrastructure for the study as well as
opportunities to spread knowledge from this project lo-
cally and internationally in collaboration with the WHO
Western Pacific Region. The results of the study will be
published in international referee-based, high-impact
scientific journals, national vocational journals, newspa-
pers, seminars, conferences and on the project’s website
and via social media campaign.
Discussion
This is a large-scale randomised controlled trial investi-
gating whether staff educational intervention is associ-
ated with a decrease, no change or even increase in use
of coercive methods and patient services, a changed glo-
bal state, treatment satisfaction and quality of life, and
team climate among staff members. This is a single-
blind, two-arm stratified cluster trial, involving hospitals
with psychiatric hospital beds across Finland. Based on
good examples abroad and extending educational inter-
ventions supporting relatives’ engagement in patients
care, we believe that the study results may be beneficial
in national and international contexts. Based on previous
literature and our own experiences, we are prepared to
face challenges in implementing and measuring the
effects of the new intervention in mental health services
and patient well-being [47, 53].
Study status
To date, we have recruited 15 hospitals, in which a total
of 28 psychiatric wards are willing to participate. Wards
were randomised in May 2016 (13 intervention wards,
15 in comparison wards).
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